Bharat Immunolog

Bharat_Immunolog03 May 2024
Pharmaceuticals
-0.40 (-1.30%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Bharat Immunolog
Bharat Immunolog
Pharmaceuticals
Bharat_Immunolog03 May 2024
-0.40 (-1.30%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Bharat Immunolog - Share Price & Details

Lowest Today
30
Highest Today
31.44
Today’s Open
31.1
Prev. Close
30.76
52 Week High
43.89
52 Week Low
20.5
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
27.56%
Upper Circuit
Lower Circuit
P/E TTM
0
P/B Ratio
-4.03
Traded Value(Cr)
0.00
EPS TTM
0
Book value
Dividend
0.00%

Price Performance

-5.60 %
1 Wk
-5.89 %
1 M
-8.75 %
3 M
27.56 %
1 Y
-13.26 %
YTD

Traded Volume Movement

Technical Details

Support 3
0
Support 2
0
Support 1
0
Pivot Point :
0
Resistance 1
0
Resistance 2
0
Resistance 3
0

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
30.36-0.40131.0927.560.00-4.03
Astrazeneca Pharma India Ltd
₹5,424.45(+90.60/1.70%)
5,424.45+90.6013,561.1371.4585.0220.71
Bliss GVS Pharma Ltd
₹119.10(-10.10/-7.82%)
119.10-10.101,246.8756.0718.271.28
Cipla Ltd
₹1,424.75(+5.20/0.37%)
1,424.75+5.20115,033.6054.7034.984.44
Amrutanjan Health Care Ltd
₹775.50(-11.10/-1.41%)
775.50-11.102,242.0227.7850.958.56
Abbott India Ltd
₹26,144.45(-459.90/-1.73%)
26,144.45-459.9055,556.9615.9248.5017.87

About Bharat Immunological & Biological Corporation Ltd

Bharat Immunological & Biological Corporation Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 131.09 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. -4.92 crores for the quarter ended December 2018. The company management includes Y K Gupta, Y K Gupta,Sandip K Lal,Alka Sharma,Mohd Aslam,Sudhanshu Vrati,Madhu Dikshit,Sanjay Kumar Mishra,Pankaj Kumar (Bharat Immunological & Biological Corporation Ltd) among others.
Chairman
Y K Gupta
Registered office
BIBCOL OPV Plant Village Chola,,Bulandshahr,Uttar Pradesh,203203
FAX :
Background
Incorporation Year1989
Face Value₹10
Market Lot1

Latest News

Will Nifty make up for Friday’s loss?
After touching a fresh peak, Nifty ended last week marginally higher as earnings, Fed meeting and election-related speculations kept investors busy. While most sectors are contributing positively except for IT, banking performance is likely to heavily influence market sentiment, analysts say. The rising VIX is indicative of potential volatility. Market can turn highly volatile in the short-run.
05 May 2024 | 05:05 PM
Godrej Properties to launch housing projects worth Rs 30,000 crore in FY25
Godrej Properties plans to launch residential projects worth Rs 30,000 crore this fiscal across major cities to achieve 20% growth in sales bookings amid strong demand, its executive chairperson Pirojsha Godrej said. In the last fiscal, the company's sales bookings jumped 84 percent to a record Rs 22,527 crore, from Rs 12,232 crore in the preceding year.
05 May 2024 | 05:26 PM
MRF Q4 Results Live : profit rise by 16.27% YOY
MRF Q4 Results: MRF declared their Q4 results on 03 May, 2024. The topline increased by 8.69% & the profit increased by 16.27% YoY. Compared to the previous quarter, the revenue grew by 3.03% and the profit decreased by 22.29%. The Selling, general & administrative expenses rose by 6.66% q-o-q & increased by 16.88% Y-o-Y. The operating income was down by 24.18% Q/Q & increased by 0.55% Y/Y.
05 May 2024 | 05:22 PM
Raymond Q4 Results: profit rise by 17.94% YOY
Raymond Q4 Results: Raymond declared their Q4 results on 03 May, 2024. The topline increased by 21.32% & the profit increased by 17.94% YoY. Compared to the previous quarter, the revenue grew by 9.32% and the profit increased by 24.91%. The Selling, general & administrative expenses rose by 3.47% q-o-q & increased by 13.97% Y-o-Y. The operating income was up by 15.49% q-o-q.
05 May 2024 | 05:21 PM
Carborundum Universal Q4 Results: profit falls by 1.66% YOY
Carborundum Universal Q4 Results: Carborundum Universal declared their Q4 results on 03 May, 2024. The topline increased by 0.13% & the profit decreased by 1.66% YoY. Compared to the previous quarter, the revenue grew by 4.32% and the profit increased by 21.15%. The Selling, general & administrative expenses rose by 2.83% q-o-q and decreased by 1.39% Y-o-Y.
05 May 2024 | 05:20 PM

How to buy Bharat Immunolog shares on nse?

To buy Bharat Immunolog shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Bharat Immunolog share price today?

The Bharat Immunolog shares price on nse is Rs.30.36 today.

What is the market cap of Bharat Immunolog shares on BSE ?

The company has a market capitalization of Rs.131.09Cr

What is the PE & PB ratio of Bharat Immunolog shares ?

PE is 0 and PB is -4.03

What is the 52 Week High and Low of Bharat Immunolog shares?

Bharat Immunolog stock price high: Rs.43.89 Bharat Immunolog stock price low: Rs.20.5